ClinicalTrials.Veeva

Menu

Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser

F

Federal University of São Paulo

Status and phase

Unknown
Phase 3

Conditions

Diabetic Retinopathy

Treatments

Procedure: Panretinal photocoagulation

Study type

Interventional

Funder types

Other

Identifiers

NCT01304225
PASCAL-001

Details and patient eligibility

About

This study will investigate the clinical efficacy and safety of the PASCAL laser (PAttern SCAn Laser) for diabetic retinopathy. Patients with proliferative or severe nonproliferative retinopathy will be treated with panretinal photocoagulation utilizing different treatment strategies. The investigators believe that using "lower" laser parameters, the clinical response may be equivalent with less adverse effects.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • proliferative or severe nonproliferative diabetic retinopathy (type 1 or type 2)
  • best corrected visual acuity of 20/50 or better
  • capability to read and follow instructions
  • capability to sign the consignment term

Exclusion criteria

  • best corrected visual acuity worse than 20/50
  • significant macular edema responsible for visual acuity lower than 20/50
  • media opacities (includes vitreous hemorrhage in the visual axis, but not a reabsorbing inferior vitreous hemorrhage)
  • previous laser treatment (PRP, focal or macular grid)
  • glaucoma (confirmed or suspicious)
  • other diseases of the retina and optic nerve
  • previous ocular surgery in the last 6 months
  • impossibility to obtain good quality images of retinography, angiography or OCT

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 3 patient groups

100ms single-shot
Active Comparator group
Description:
Panretinal photocoagulation utilizing 100ms pulse duration, moderate intensity burns, in a single-shot fashion
Treatment:
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation
20ms multiple-shot
Experimental group
Description:
Panretinal photocoagulation utilizing 20ms pulse duration, moderate intensity burns, in a multiple-shot fashion
Treatment:
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation
20ms multiple-shot, barely visible
Experimental group
Description:
Panretinal photocoagulation utilizing 20ms pulse duration, barely visible intensity burns, in a multiple-shot fashion
Treatment:
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation
Procedure: Panretinal photocoagulation

Trial contacts and locations

1

Loading...

Central trial contact

Renato M Passos, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems